Sartorius Stedim Biotech ...

PNK: SDMHF · Real-Time Price · USD
216.65
-3.35 (-1.52%)
At close: May 30, 2025, 3:33 PM

Sartorius Stedim Biotech S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
219.2M 401.1M 1.13B 646.72M
Depreciation & Amortization
301.7M 237.6M 181.7M 141.56M
Stock-Based Compensation
n/a n/a n/a 900K
Other Working Capital
43.4M -102.6M -133.4M 129.65M
Other Non-Cash Items
43.2M -83M -348.5M 53.45M
Deferred Income Tax
n/a n/a n/a -900K
Change in Working Capital
251M 190.7M -351.3M -145.75M
Operating Cash Flow
815.1M 746.4M 612.3M 695.97M
Capital Expenditures
-339.8M -473.6M -430.6M -323.99M
Cash Acquisitions
n/a -2.24B -515.6M -141.67M
Purchase of Investments
-100K n/a n/a -323.99M
Sales Maturities Of Investments
n/a n/a n/a 323.99M
Other Investing Acitivies
-100K -8.2M -11.3M 432K
Investing Cash Flow
-340M -2.72B -957.5M -465.23M
Debt Repayment
-861.9M 2.32B 392.4M -5.5M
Common Stock Repurchased
-1.9M n/a -3.2M n/a
Dividend Paid
-67.1M -132.7M -116.1M -62.68M
Other Financial Acitivies
-177.8M -205.3M -52.4M -9.52M
Financial Cash Flow
84.9M 1.99B 220.7M -71.71M
Net Cash Flow
562.3M 9.5M -116.5M 163.86M
Free Cash Flow
475.3M 272.8M 181.7M 371.98M